Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy

Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in patients with advanced non-small cell lung cancer treated with immunotherapy plus chemotherapy

Abstract Backgroud Immune checkpoint inhibitor (ICI) plus chemotherapy has become the standard of care for advanced non-small cell lung cancer (NSCLC). Nonetheless, reliable efficacy biomarkers of ICI plus chemotherapy are lacking. In this research, we sought to explore efficacy biomarkers and const...

Full description

Saved in:
Bibliographic Details
Main Authors: Shan Liao, Huiying Sun, Hao Lu, Jiani Wu, Jianhua Wu, Zhe Wu, Jingle Xi, Wangjun Liao, Yuanyuan Wang
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Cancer
Subjects:
Non-small cell lung cancer
Neutrophil lymphocyte ratio
Immunochemotherapy
Efficacy prediction
Prognostic biomarker
Online Access:https://doi.org/10.1186/s12885-025-13811-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-13811-y

Similar Items